North American Vaccine (NVX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : North American Vaccine (NVX)

NVX 1.035

-5.5%

Dec 30 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Don W Stone who wrote (21)	1/23/1997 8:36:00 AM
From: kech	of 35

Don and Tom (Stone) - I looked back at when I first bought NVX and it was 1992 so I too qualify as a long time holder (sufferer until last year). I appreciate what you say about patience and what seems to be the easy to misinterpret reports on various FDA findings - it seems to have happened many times. I do have one lingering doubt about this one though which is that they seem to take much longer than competitors to get their vaccines approved. It seemed like Merck's just sailed through compared to NVX. We always hear that NVX's vaccines are safer etc., shouldn't these be easier to approve than others? Is this a management problem at NVX or do the delays and lags have something to do with the new acellular process NVX is using? I know, as you say, the FDA process is a tortured one, but it doesn't seem to be quite as tortured for competitors - unless maybe I am wrong on this. What is the story?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next